MedTrace Logo

ERr 731® Formulation Evaluation

NCT05959057 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2023-10-30

No results posted yet for this study

Summary

A comparison of an enteric coated and micro-coated formulation of ERr 731®

Conditions

Interventions

DIETARY_SUPPLEMENT

ERr 731 - Micro-coated

natural extract of the Rheum Rhaponticum L plant (Siberian rhubarb). The primary active constituents of ERr 731® are hydroxystilbenes, primarily rhaponticin and desoxyrhaponticin.

DIETARY_SUPPLEMENT

ERr 731 - Enteric coated

natural extract of the Rheum Rhaponticum L plant (Siberian rhubarb). The primary active constituents of ERr 731® are hydroxystilbenes, primarily rhaponticin and desoxyrhaponticin.

Sponsors & Collaborators

  • Metagenics, Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
35 Years
Max Age
64 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-05-24
Primary Completion
2023-08-18
Completion
2023-08-18

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05959057 on ClinicalTrials.gov